Pregnancy Outcomes, Placenta Histopathology and Immunohistochemistry in Patients with a History of Recurrent Pregnancy Loss or Implantation Failure Undergoing In Vitro Fertilization.

IF 1.9
SiWon Lee, SuYun Ling, Jade Rechtzigel, Chandra C Paff Shenoy, Sylvie Girard
{"title":"Pregnancy Outcomes, Placenta Histopathology and Immunohistochemistry in Patients with a History of Recurrent Pregnancy Loss or Implantation Failure Undergoing In Vitro Fertilization.","authors":"SiWon Lee, SuYun Ling, Jade Rechtzigel, Chandra C Paff Shenoy, Sylvie Girard","doi":"10.1016/j.xfss.2026.09.004","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To evaluate pregnancy outcomes, placental histopathology, and placental immune markers in pregnancies after in vitro fertilization (IVF) with a history of recurrent pregnancy loss (RPL) or recurrent implantation failure (RIF).</p><p><strong>Design: </strong>Retrospective cohort study.</p><p><strong>Setting: </strong>Single academic center.</p><p><strong>Subjects: </strong>Patients who underwent IVF with a history of RPL or RIF and age- and body mass index (BMI)-matched spontaneous pregnancies and IVF patients without a history of RPL or RIF between 2018 and 2023.</p><p><strong>Exposure: </strong>IVF with a history of RPL or RIF.</p><p><strong>Main outcome measures: </strong>Placental histopathology, placental immunohistochemical markers.</p><p><strong>Results: </strong>Among 2,215 IVF cycles, 407 resulted in live births within our hospital system. We analyzed 325 IVF patients (52 with RPL, 30 with RIF and 243 without RPL/RIF) and 197 patients with spontaneous pregnancies as a reference group. Placental histopathology was available for 283 patients and immunohistochemistry (IHC) was conducted on 133 samples. After adjusting for maternal age and BMI, and correcting for multiple comparisons, pregnancies in the IVF-no RPL/RIF group had statistically increased incidence of postpartum hemorrhage, and a trend towards preeclampsia was observed in the IVF-RPL group. In placental histopathology, increased incidence of fetal vascular malperfusion, inflammatory lesions such as chronic villitis, and intervillous thrombi was noted in IVF pregnancies, especially in IVF-RPL group. IHC analysis showed significantly higher numbers of CD163+ and CD68+ placental macrophages in all IVF groups, and markedly high CD163+ cells in IVF-RIF group. IL-6 levels did not differ between groups.</p><p><strong>Conclusion: </strong>IVF pregnancies, especially in patients with a history of RPL or RIF, are associated with adverse pregnancy outcomes and distinct placental histopathology, and elevated placental macrophages. These findings highlight the importance of individualized counseling and prenatal/postnatal surveillance although additional work is needed in larger multicenter cohorts to fully establish the pathophysiological association.</p>","PeriodicalId":73012,"journal":{"name":"F&S science","volume":" ","pages":""},"PeriodicalIF":1.9000,"publicationDate":"2026-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"F&S science","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.xfss.2026.09.004","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: To evaluate pregnancy outcomes, placental histopathology, and placental immune markers in pregnancies after in vitro fertilization (IVF) with a history of recurrent pregnancy loss (RPL) or recurrent implantation failure (RIF).

Design: Retrospective cohort study.

Setting: Single academic center.

Subjects: Patients who underwent IVF with a history of RPL or RIF and age- and body mass index (BMI)-matched spontaneous pregnancies and IVF patients without a history of RPL or RIF between 2018 and 2023.

Exposure: IVF with a history of RPL or RIF.

Main outcome measures: Placental histopathology, placental immunohistochemical markers.

Results: Among 2,215 IVF cycles, 407 resulted in live births within our hospital system. We analyzed 325 IVF patients (52 with RPL, 30 with RIF and 243 without RPL/RIF) and 197 patients with spontaneous pregnancies as a reference group. Placental histopathology was available for 283 patients and immunohistochemistry (IHC) was conducted on 133 samples. After adjusting for maternal age and BMI, and correcting for multiple comparisons, pregnancies in the IVF-no RPL/RIF group had statistically increased incidence of postpartum hemorrhage, and a trend towards preeclampsia was observed in the IVF-RPL group. In placental histopathology, increased incidence of fetal vascular malperfusion, inflammatory lesions such as chronic villitis, and intervillous thrombi was noted in IVF pregnancies, especially in IVF-RPL group. IHC analysis showed significantly higher numbers of CD163+ and CD68+ placental macrophages in all IVF groups, and markedly high CD163+ cells in IVF-RIF group. IL-6 levels did not differ between groups.

Conclusion: IVF pregnancies, especially in patients with a history of RPL or RIF, are associated with adverse pregnancy outcomes and distinct placental histopathology, and elevated placental macrophages. These findings highlight the importance of individualized counseling and prenatal/postnatal surveillance although additional work is needed in larger multicenter cohorts to fully establish the pathophysiological association.

妊娠结局、胎盘组织病理学和免疫组织化学在有复发性妊娠丢失或植入失败史的体外受精患者中的应用
目的:评价有复发性妊娠丢失(RPL)或复发性植入失败(RIF)史的体外受精(IVF)后妊娠结局、胎盘组织病理学和胎盘免疫标志物。设计:回顾性队列研究。设置:单一学术中心。研究对象:2018年至2023年间接受体外受精且有RPL或RIF史且年龄和体重指数(BMI)匹配的自然妊娠患者和无RPL或RIF史的体外受精患者。暴露:有RPL或RIF病史的IVF。主要观察指标:胎盘组织病理学、胎盘免疫组织化学标志物。结果:在2215个试管婴儿周期中,407例在我院系统内活产。我们分析了325例IVF患者(52例RPL, 30例RIF, 243例无RPL/RIF)和197例自然妊娠患者作为参照组。283例患者行胎盘组织病理学检查,133例标本行免疫组化(IHC)。在调整了产妇年龄和BMI,并对多重比较进行校正后,IVF-no RPL/RIF组妊娠的产后出血发生率有统计学意义上的增加,并且在IVF-RPL组中观察到先兆子痫的趋势。在胎盘组织病理学上,IVF妊娠,特别是IVF- rpl组,发现胎儿血管灌注不良、慢性绒毛炎等炎症病变和绒毛间血栓的发生率增加。免疫组化分析显示,各IVF组CD163+和CD68+胎盘巨噬细胞数量均显著增加,IVF- rif组CD163+细胞数量显著增加。各组间IL-6水平无显著差异。结论:IVF妊娠,特别是有RPL或RIF病史的患者,与不良妊娠结局和不同的胎盘组织病理学以及胎盘巨噬细胞升高有关。这些发现强调了个性化咨询和产前/产后监测的重要性,尽管需要在更大的多中心队列中进行额外的工作,以充分建立病理生理联系。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
F&S science
F&S science Endocrinology, Diabetes and Metabolism, Obstetrics, Gynecology and Women's Health, Urology
CiteScore
2.00
自引率
0.00%
发文量
0
审稿时长
51 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书